PURPOSE: Autoimmune diseases are thought to be caused by a loss of self-tolerance of the immune system. One candidate marker of immune dysregulation in autoimmune disease is the presence of increased double negative T cells (DNTs) in the periphery. DNTs are characteristically elevated in autoimmune lymphoproliferative syndrome, a systemic autoimmune disease caused by defective lymphocyte apoptosis due to Fas pathway defects. DNTs have also been found in the peripheral blood of adult patients with systemic lupus erythematosus (SLE), where they may be pathogenic. DNTs in children with autoimmune disease have not been investigated. METHODS: We evaluated DNTs in pediatric patients with SLE, mixed connective tissue disease (MCTD), juvenile idiopathic arthritis (JIA), or elevated antinuclear antibody (ANA) but no systemic disease. DNTs (CD3(+)CD56(-)TCRαβ(+)CD4(-)CD8(-)) from peripheral blood mononuclear cells were analyzed by flow cytometry from 54 pediatric patients including: 23 SLE, 15 JIA, 11 ANA and 5 MCTD compared to 28 healthy controls. RESULTS: Sixteen cases (29.6 %) had elevated DNTs (≥2.5 % of CD3(+)CD56(-)TCRαβ(+) cells) compared to 1 (3.6 %) control. Medication usage including cytotoxic drugs and absolute lymphocyte count were not associated with DNT levels, and percentages of DNTs were stable over time. Analysis of multiple phenotypic and activation markers showed increased CD45RA expression on DNTs from patients with autoimmune disease compared to controls. CONCLUSION: DNTs are elevated in a subset of pediatric patients with autoimmune disease and additional investigations are required to determine their precise role in autoimmunity.
PURPOSE:Autoimmune diseases are thought to be caused by a loss of self-tolerance of the immune system. One candidate marker of immune dysregulation in autoimmune disease is the presence of increased double negative T cells (DNTs) in the periphery. DNTs are characteristically elevated in autoimmune lymphoproliferative syndrome, a systemic autoimmune disease caused by defective lymphocyte apoptosis due to Fas pathway defects. DNTs have also been found in the peripheral blood of adult patients with systemic lupus erythematosus (SLE), where they may be pathogenic. DNTs in children with autoimmune disease have not been investigated. METHODS: We evaluated DNTs in pediatric patients with SLE, mixed connective tissue disease (MCTD), juvenile idiopathic arthritis (JIA), or elevated antinuclear antibody (ANA) but no systemic disease. DNTs (CD3(+)CD56(-)TCRαβ(+)CD4(-)CD8(-)) from peripheral blood mononuclear cells were analyzed by flow cytometry from 54 pediatric patients including: 23 SLE, 15 JIA, 11 ANA and 5 MCTD compared to 28 healthy controls. RESULTS: Sixteen cases (29.6 %) had elevated DNTs (≥2.5 % of CD3(+)CD56(-)TCRαβ(+) cells) compared to 1 (3.6 %) control. Medication usage including cytotoxic drugs and absolute lymphocyte count were not associated with DNT levels, and percentages of DNTs were stable over time. Analysis of multiple phenotypic and activation markers showed increased CD45RA expression on DNTs from patients with autoimmune disease compared to controls. CONCLUSION:DNTs are elevated in a subset of pediatric patients with autoimmune disease and additional investigations are required to determine their precise role in autoimmunity.
Authors: Karin Fischer; Simon Voelkl; Jana Heymann; Grzegorz K Przybylski; Krishna Mondal; Monika Laumer; Leoni Kunz-Schughart; Christian A Schmidt; Reinhard Andreesen; Andreas Mackensen Journal: Blood Date: 2004-11-30 Impact factor: 22.113
Authors: Jack J H Bleesing; Margaret R Brown; Cynthia Novicio; David Guarraia; Janet K Dale; Stephen E Straus; Thomas A Fleisher Journal: Clin Immunol Date: 2002-07 Impact factor: 3.969
Authors: Vaidehi R Chowdhary; Ashton Krogman; Ashenafi Y Tilahun; Mariam P Alexander; Chella S David; Govindarajan Rajagopalan Journal: J Immunol Date: 2017-05-03 Impact factor: 5.422
Authors: Joshua D Milner; Tiphanie P Vogel; Lisa Forbes; Chi A Ma; Asbjørg Stray-Pedersen; Julie E Niemela; Jonathan J Lyons; Karin R Engelhardt; Yu Zhang; Nermina Topcagic; Elisha D O Roberson; Helen Matthews; James W Verbsky; Trivikram Dasu; Alexander Vargas-Hernandez; Nidhy Varghese; Kenneth L McClain; Lina B Karam; Karen Nahmod; George Makedonas; Emily M Mace; Hanne S Sorte; Gøri Perminow; V Koneti Rao; Michael P O'Connell; Susan Price; Helen C Su; Morgan Butrick; Joshua McElwee; Jason D Hughes; Joseph Willet; David Swan; Yaobo Xu; Mauro Santibanez-Koref; Voytek Slowik; Darrell L Dinwiddie; Christina E Ciaccio; Carol J Saunders; Seth Septer; Stephen F Kingsmore; Andrew J White; Andrew J Cant; Sophie Hambleton; Megan A Cooper Journal: Blood Date: 2014-10-30 Impact factor: 22.113
Authors: Jonathan M Eby; Hee-Kap Kang; Jared Klarquist; Shilpak Chatterjee; Jeffrey A Mosenson; Michael I Nishimura; Elizabeth Garrett-Mayer; B Jack Longley; Victor H Engelhard; Shikhar Mehrotra; I Caroline Le Poole Journal: Pigment Cell Melanoma Res Date: 2014-07-21 Impact factor: 4.693
Authors: Karen L Bride; Tiffaney Vincent; Kim Smith-Whitley; Michele P Lambert; Jack J Bleesing; Alix E Seif; Catherine S Manno; James Casper; Stephan A Grupp; David T Teachey Journal: Blood Date: 2015-10-26 Impact factor: 22.113
Authors: Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam Journal: Am J Clin Pathol Date: 2017-02-01 Impact factor: 2.493
Authors: Jahnavi Aluri; Alicia Bach; Saara Kaviany; Luana Chiquetto Paracatu; Maleewan Kitcharoensakkul; Magdalena A Walkiewicz; Christopher D Putnam; Marwan Shinawi; Nermina Saucier; Elise M Rizzi; Michael T Harmon; Molly P Keppel; Michelle Ritter; Morgan Similuk; Elaine Kulm; Michael Joyce; Adriana A de Jesus; Raphaela Goldbach-Mansky; Yi-Shan Lee; Marina Cella; Peggy L Kendall; Mary C Dinauer; Jeffrey J Bednarski; Christina Bemrich-Stolz; Scott W Canna; Shirley M Abraham; Matthew M Demczko; Jonathan Powell; Stacie M Jones; Amy M Scurlock; Suk See De Ravin; Jack J Bleesing; James A Connelly; V Koneti Rao; Laura G Schuettpelz; Megan A Cooper Journal: Blood Date: 2021-05-06 Impact factor: 25.476